Evidence map›Paper›PMID 41953963›Full record

SynthesisThe Journal of antimicrobial chemotherapy2026

Definitions and rates of treatment failure in females with uncomplicated urinary tract infection: a systematic literature review.

Meghan E Luck, Amber Martin, Salima Punja, Joanna Kamar, Priccila Zuchinali, Amy G Edgecomb, Jeffrey J Ellis

Abstract readSystematic Review
In one paragraph

Synthesis in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Meghan E LuckGSK, Collegeville, PA, USA.
Amber MartinEvidence Synthesis, Evidera Inc., Waltham, MA, USA.
Salima PunjaEvidence Synthesis, Evidera Inc., Waltham, MA, USA.
Joanna KamarEvidence Synthesis, Evidera Inc., Waltham, MA, USA.
Priccila ZuchinaliEvidence Synthesis, Evidera Inc., Waltham, MA, USA.
Amy G EdgecombGSK, Collegeville, PA, USA.
Jeffrey J EllisGSK, Collegeville, PA, USA.

Funding

GSK
6 · The paper itself

Abstract

backgroundUncomplicated urinary tract infections (UTIs) affect ∼50%-60% of women. Treatment failure can have adverse effects on antibiotic resistance, healthcare utilization and quality of life. The lack of consistently applied definitions of treatment failure prevents comparisons between studies of UTI treatments.

objectivesWe conducted a systematic literature review to investigate definitions of treatment failure in UTI and the corresponding failure rates.

methodsMEDLINE, Embase and CENTRAL databases were searched from 2011 to 2024 and relevant conference proceedings from 2021 to 2024 for English language studies reporting rates of treatment failure in females aged ≥12 years with uncomplicated UTI.

resultsPublications included reported 14 clinical trials, 11 non-interventional observational studies with chart review and 10 healthcare database studies. Treatment failure definitions were classified as microbiological, clinical, antibiotic prescription based or a composite of these. Evaluation timepoints typically ranged from 1 to 30 days post-treatment. In clinical trials, failure rates varied from 0.8% to 83%, often with marked differences between microbiological, clinical and prescription definitions within the same trial. Rates of treatment failure using combined endpoints, including prescription failure with a healthcare encounter in database studies, were generally more consistent (6.87%-16.7%). Few studies assessed time to symptom resolution. Prescription failure or additional healthcare visits frequently occurred after a median 2-4 weeks.

conclusionsTreatment failure definitions have been variably defined in the literature. Symptom scores in clinical trials and the need for additional antibiotics or healthcare visits are meaningful outcomes that could underly treatment failure definitions in future studies. The optimal time for each outcome assessment needs further evaluation.

Indexed as

Anti-Bacterial AgentsUrinary Tract InfectionsFemaleHumansTreatment FailureAnti-Bacterial Agents

Identifiers

PMID41953963
PMCPMC13069487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.